Abstract Angiotensin TI (Ang TI), a vasoactive octapeptide, has been implicated in cardiac growth and the development of hypertrophy and fibrosis secondary in hypertensive disease. These consequences of Ang II imply an effect on the function and morphology of cardiac interstitial cells (fibroblasts). The present investigation was designed to (1) determine whether neonatal heart fibroblasts (NHFs) possess functional Ang II receptors on their plasma membrane and (2) examine the effects of Ang II on NHFs in vitro using three-and two-dimensional (3D and 2D, respectively) Ang II receptors and 3,1-integrin, indicating a functional relation between Ang II and f,1-integrin on cardiac fibroblasts. We conclude that Ang II influences the ability of cardiac fibroblasts to contract 3D collagen gels and the regulation of membranebound integrins in both 2D and 3D cultures of NHFs. (Circ Res. 1994;74:291-298.) 
Abstract Angiotensin TI (Ang TI), a vasoactive octapeptide, has been implicated in cardiac growth and the development of hypertrophy and fibrosis secondary in hypertensive disease. These consequences of Ang II imply an effect on the function and morphology of cardiac interstitial cells (fibroblasts). The present investigation was designed to (1) determine whether neonatal heart fibroblasts (NHFs) possess functional Ang II receptors on their plasma membrane and (2) examine the effects of Ang II on NHFs in vitro using three-and two-dimensional (3D and 2D, respectively) cultures. Several analytic techniques were used to test the specific questions of the present study. Since cardiac fibroblast phenotype can be influenced by culture conditions, both 2D and 3D cultures were used in the present investigations. Reverse-transcriptase polymerase chain reaction and radioligand binding analysis were used to test for the presence of Ang II receptors on NHFs. Both revealed that NHFs in 2D culture possess Ang II receptor mRNA and Ang II receptors. When isolated NHFs were cultured in 3D collagen gels and treated with Ang II, gel contraction was stimulated by ) ecent evidence has suggested a role for angiotensin II (Ang II), a vasoactive octapeptide, as a growth-regulating factor important both in normal heart development and in hypertrophy from systemic hypertension.' Pressure-overload cardiac hypertrophy and neonatal development are characterized by increases in extracellular matrix (ECM) accumulation of collagen and associated glycoproteins as well as by increases in myocyte size and ventricular wall thickness. 2 The association of Ang II with the accumulation of interstitial matrix components (ie, collagen and elastin) in hypertrophy that occurs during development or disease has recently been given considerable attention. For example, reducing endogenous Ang II with angiotensin-converting enzyme inhibitors attenuates the normal accumulation of both collagen and elastin in the hearts of developing young rats,3 whereas increased Ang II levels stimulate collagen synthesis in cultured vascular smooth muscle cells. 4 In vivo experiments cannot distinguish the variety of serum factors, such as hormones and growth factors, that may be partially respon-sible for the Ang IT-associated effects on cardiac hypertrophy during development and disease. In addition, the most probable site of Ang II action must involve myocardial fibroblasts, since they are responsible for synthesizing the majority of ECM proteins; however, evidence for the presence of Ang II receptors on cardiac fibroblasts has only been recently demonstrated. 2, 3, 5 Indeed, the direct effects of Ang II on cardiac fibroblasts warrant further research.
Integrins have been recognized as a widely expressed family of cell surface adhesion receptors that are noncovalently linked af3 heterodimers. 6 Multiple integrins are expressed on the surface of the cellular components of the heart and play an important role as signaling receptors in a variety of cell types.6 A particularly important feature of integrins is that they undergo activation. For example, in adhesion processes, integrins provide the strong adhesion but only after activation by other stimuli, which can include soluble mediators such as hormones and cytokines.6 Activation of and signaling by integrins result in a variety of influences on the cell that play roles in development and cellular differentiation,7 platelet and lymphocyte function, fibroblast cell adhesion, T-cell activation and proliferation, and ECM regulation.6'8 Integrins are important regulators in early cardiac development, providing positional information for migrating and differentiating cells.8 They are also important regulators of the intimate actions between myocytes, ECM proteins, and cytoskel-etal components in the adult heart.9 In an in vitro assay using three-dimensional (3D) collagen gels to assess cell function, P,-integrin mediates gel contraction by neonatal heart fibroblasts (NHFs) by various growth factors. 10 Cell phenotype and function can be influenced by culture conditions. Cardiac fibroblasts in situ reside within a collagenous network and are elongate and bipolar in shape." Plated in two-dimensional (2D) culture, these cells will change from elongate to a flat shape with stellate projections" and actively synthesize collagens. Fibroblasts plated in 3D collagen gels maintain their elongation and have less projections" and lower rates of collagen synthesis (versus cells plated in 2D culture), which are characteristics similar to in vivo conditions. Collagen gel contraction assays are often used as an in vitro model for wound contraction12 and connective tissue morphogenesis,'0 and the contraction process has been characterized in great detail. 10 The interaction of fibroblasts with a 3D collagen lattice affects cellular activities such as protein synthesis and proliferation10 and thus provides a unique model for fibroblast responses in vitro. NHFs in attached collagen gels interact with the collagen via specific integrin receptors, and this interaction results in gel contraction.'3 Cardiac fibroblasts in vivo interact with myocytes, and together, they regulate mechanical properties of the heart.8 Similarly, 3D collagen gels in vitro reestablish the interaction of fibroblasts with their collagen matrix." Because culture conditions influence cell phenotype and function, the present study examines NHFs in both 2D and 3D cultures.
In the present investigation, a variety of in vitro models were used to (1) procedures."3, 5Briefly, minced heart tissue was subjected to collagenase digestion, and the dissociated cells were plated in 150-cm2 culture flasks with Dulbecco's modified essential media (DMEM) supplemented with 10% neonatal bovine serum, 5% fetal bovine serum, 0.5 U/mL penicillin G, 0.5 ,ug/mL streptomycin, and 2 pg/mL amphotericin B (10/5-DMEM). After "-1 to 2 hours, the medium was aspirated, and the attached cells were washed with Moscona's saline. Forty milliliters of 10/5-DMEM was added, and cells were grown at 37°C in 5% C02/95% air until confluent. Cells from subsequent passages 3 to 10 were used for all experiments.
Ang II Receptors
Saturation binding analysis was used to test the presence of Ang II receptors on NHFs. Reverse-transcriptase (RT) polymerase chain reaction (PCR) was used to test whether NHFs possessed mRNA for Ang II receptors.
The presence of Ang II receptors on NHFs was determined using a modification of the method of Aceto and Baker. 16 Briefly, NHFs were plated in 35-mm six-well culture plates at a density of 200 000 per well in 10/5-DMEM. After 24 hours, the attached cells were washed with Moscona's saline and fed with 3 mL of serum-free DMEM. Cells were grown in serumfree DMEM for 4 to 5 days before conducting receptorbinding experiments. Cells were washed three times with 1 mL of an incubation buffer (50 mmol/L Tris, 120 mmol/L NaCl, 4 mmol/L KCl, 1 mmol/L CaCI2, 1 mmol/L MgCl2, 2 mg/mL dextrose, 10 ,gg/mL bacitracin, and 0.25% bovine serum albumin [BSA] at pH 7.5 and 25°C). A saturation radioligandbinding assay was conducted as follows. One milliliter of incubation buffer was then added either alone or in combination with varying concentrations of 'I-Ang II. Nonspecific binding was determined in the presence of 10 nmol/L unlabeled Ang II. The cells were incubated for 60 minutes at room temperature, after which the reaction mixture was removed by aspiration. The cells were then washed three times with incubation buffer, after which 200 ,uL of lysis solution (0.25N NaOH and 0.5% sodium dodecyl sulfate [SDS] ) was added to each well. After a 10-minute incubation at room temperature, wells were washed with an additional 500 ,uL of the NaOH/ SDS solution, and the solutions were transferred into vials for gamma counting. Identical wells for each condition were used for determination of protein content. Total protein was determined by the Pierce assay (Pierce Chemical Co, Rockford, Ill).
Affinity (Kd) and receptor number (Bm.) were determined using saturation analysis (0 to 8 nmol 'I-Ang II; specific activity, 2175 Ci/mmol) and calculated according to the method of Lundeen and Gordon.17 The data were then graphed as a Scatchard plot to demonstrate linearity of transformed data. Ang II receptor-binding experiments were repeated at least three times, and results are expressed as moles per milligram protein.
RT-PCR methodology determined whether NHFs were expressing mRNA for Ang II (type 1) receptors, because this receptor mediates all of the hemodynamic manifestations of Ang 11.18 Total RNA was isolated from confluent NHFs in 2D culture using the one-step guanidinium thiocyanate method.19 RT-PCR was carried out with the GeneAmp RNA PCR kit (Perkin-Elmer, Norwalk, Conn) using 2 j,g of total RNA per reaction. Briefly, Moloney murine leukemia virus RT and random primers were used for cDNA synthesis from the RNA. The cDNA was amplified with Amplitaq DNA polymerase and primers for the rat aortic vascular smooth muscle Ang II (type 1) receptor.20 Specifically, cDNA (rat) sequences nt 296 to 318 (ACCTATGTAAGATCGCTTCGGC) and nt 854 to 875 (TACGCTATGCAGATGGTGATGG) were used.20 Primer Detective software (Clontech, La Jolla, Calif) was then used to select the Ang II primers for this experiment. These primers were synthesized by the Oligonucleotide Synthesis Facility at the University of South Carolina (Institute for Biological and Research Technology, Columbia, SC). Primers for 3-actin (Clontech) were used to test the integrity of the RNA. Thermal cycling was carried out for 30 cycles at 95°C for 1 minute, 60°C for 2 minutes, and 72°C for 3 minutes. Amplification of the appropriate DNA was verified by separation of RT-PCR products on 2% agarose gels along with HindlIldigested A-DNA for size reference. Gels were stained with 10 ,ug/mL ethidium bromide and photographed against UV light with a Polaroid camera.
Both ligand-binding assays and RT-PCR analyses for Ang II receptors were attempted in 3D collagen gels. The collagen gels retained a large amount of radioactivity such that concentration differences could not be distinguished, and attempts to extract RNA from fibroblasts in collagen gels has not been successful to date in this laboratory.
Collagen Gel Contraction
The second set of experiments used collagen gel contraction to determine whether Ang II had an effect on NHF interaction with surrounding ECM components. Collagen gel contraction was used to test the direct effects of Ang II on NHFs in a 3D in vivo-like medium. Confluent NHFs in 15-cm2 polystyrene culture flasks were trypsinized (0.25% trypsin in 0.1% EDTA) and washed three times in serum-free DMEM. A total of 4x 105 cells per milliliter were treated with 10 ,ug/mL Ang II, 10 ,ug/mL [ 
Immunofluorescence
The distribution of ,31-integrin on NHFs was examined by confocal microscopy after indirect immunofluorescence staining of p1-integrin. Immunofluorescence was used to locate the presence of f31-integrins on the surface of NHFs, both in 2D
and 3D cell culture. The collagen minigels were prepared identically to the 1-mL gels (described previously), except 50 000 cells per milliliter were treated with or without hormone, and total gel volume was 25 ,L. At 24 and 96 hours after the addition of 10 ,g/mL Ang II, NHFs cultured on laminin-coated coverslips in 35-mm culture plates or in collagen minigels were washed three times with PBS and fixed with 2% paraformaldehyde for 10 or 90 minutes, respectively, followed by three 5-or 90-minute washes in PBS. Fixed cells or gels were stored in PBS with 0.2% azide at 4°C in the dark until analysis.
Immunofluorescence procedures involved washing cells in 1% glycine in PBS for 15 or 90 minutes and rinsing three times for 5 or 90 minutes in PBS before the addition of the primary antibody (50 ,ug/mL ,31-integrin IgG). Cells were incubated in primary antibody for 30 or 90 minutes at 37°C, followed by three 5-or 90-minute rinses in PBS with 0.5% BSA. Cells were then incubated in the presence of the fluorescein isothiocyanate-tagged secondary antibody (50 ,ug/mL) for an additional 30 or 90 minutes at 37°C and washed three times for 5 or 90 minutes with PBS/0.5% BSA. The coverslips were mounted on glass slides with PBS/10% glycerol (1: 3). The minigels were set in welled-glass slides with 0.1% 1,4-diazabicyclo[2.2.2]octane in PBS/glycerol (1:1). Images of stained cells or gels were captured by laser-scanning confocal microscopy (MRC600 laser scanning confocal imaging system, Biorad, Cambridge, Mass), with the manual gain set identically for each image under all experimental conditions. Immunofluorescence experiments were repeated at least three times. 1% aprotinin, 1 ,g/mL pepstatin A, 2 mmol/L leupeptin, and 1 ,g/mL benzamidine). The samples were centrifuged at 15 OOOg for 30 minutes, and the supernatant was used for immunoprecipitation. Supernatants were counted for incorporation of 1251 into cells before immunoprecipitation. Preimmune IgGs (100 ,g/mL) and protease inhibitor cocktail were added to the supernatants and incubated for 4 hours in an end-over-end fashion, followed by the addition of 100 gL of protein A/Sepharose 4B (50% slurry in PBS) and protease inhibitor cocktail and incubation for 1 hour. This mixture was then centrifuged at 10 000g for 10 minutes, and the supernatant was incubated with anti-,31-integrin IgG (100 ,ug/mL) for 8 hours in the presence of protease inhibitor cocktail. Incubation was carried out an additional hour in the protein A/Sepharose slurry. The protein A/Sepharose with bound proteins was washed as follows: five times with buffer 1 (1% Triton X-100, 0.5 mol/L NaCl, 10 mmol/L Tris, pH 7.4, and 1 mmol/L MnCl2), three times with buffer 2 (1% Triton X-100, 0.5% deoxycholate, 0.1 mol/L NaCl, 10 mmol/L Tris, pH 7.6, and 1 mmol/L MnCl2), and two times with PBS. Samples were solubilized by boiling in SDS loading buffer and subjected to nonreducing SDS-polyacrylamide gel electrophoresis and autoradiography.21 Bands for t1-integrin were determined by comparison with size standards and quantitated by soft laser densitometry. The blots were exposed for 2, 4, 6, and 8 hours to ensure that scanning was performed within the linear range of densitometry. Relative absorbance was divided by total incorporated counts for each respective sample in an effort to standardize relative quantitation. Immunoprecipitation experiments were performed at least three times.
Statistics
Data from saturation experiments were subjected to Lundon and Scatchard analysis for determination of receptor Kd and Bmax. A 2x4 (condition xtime) ANOVA was used to test differences in area between Ang Il-treated and control cells over 24, 48, 72 , and 96 hours in the collagen gel contraction experiments. Immunoprecipitation studies were analyzed by a two-way (condition) ANOVA using the densitometry units (peak area per total counts incorporated) for (Fig 1, left) . Binding demonstrated saturation at '--7 nmol/L (see Fig 1, left, inset) (Fig 1, right) . The Ang II (type 1) receptor band was of a size similar to that shown previously.20 Together, these data indicate the presence of Ang II receptors on isolated heart fibroblasts.
Collagen Gel Contraction
Collagen gel contraction experiments showed a significant main effect for area (enhanced contraction evidenced by decreased gel area) of the 3D collagen gels with the Ang II treatment versus control gels (Fig 2,  left) . Figures express change in gel area as percentage of control gel area. Student-Newman-Keuls post hoc analysis revealed that significant differences in gel contraction occurred at the 24-, 48-, 72-, and 96-hour time points (Fig 2, right; (Fig 3, P<.05 ). When collagen gels were incubated with /3-integrin antibody or both Ang LI and 10 gg/mL /31-integrin antibody, gel contraction was completely abolished, even after 96 hours (Fig 4,  P<.05 ).
Immunofluorescence
Confocal microscopic localization of /31-integrin shows more intense staining in the 2D Ang II-treated cells versus control cells (Fig 5) . The more concentrated staining appears to be distributed in the bottom focal plane between the cell and the culture dish, with intense staining under the nucleus. The figures represent substrate-level cell-surface sections, where the gain was set for control conditions and held constant for all experimental images. 
Immunoprecipitation
Results from immunoprecipitation experiments show a relative increase in f31-integrin on the surface of Ang lI-treated cells versus control cells (Fig 7) by gel electrophoresis. The arrows on Fig 7 mark 
Discussion
The ECM in the heart is important for contraction of the extracellular collagen network by tension.8 9 Directly involved in the regulation of ECM components and contraction are the cardiac fibroblasts, which are at least in part responsible for the normal ECM adaptation of the myocardium, which may in turn set the stage for pathological hypertrophy and ventricular dysfunction in Z96h hypertension and hypertrophy.28, Although Ang IL has been implicated in regulating cardiac ECM morphology and function, the present study provides evidence for direct localization and effects of Ang IL on cardiac fibroblasts, which are responsible for the synthesis of many ECM components in the myocardium. 21, 22 The present study used both 2D and 3D culture systems to examine the effects of Ang II on neonatal heart fibroblasts to control for the phenotypic changes often seen when isolating cells into culture. The results 11 [All]-treated cultures). Treatment with both 10 ug/mL All and 10 rg/mL anti-f3-integrin antibody (both) also resulted in complete inhibition of gel contraction as well (*P<.05 vs All). of most experimental procedures in the present study
The larger spots seen in this figure are more intense staining of exhibited similar responses to Ang II in both 2D and 3D p1-integrin on individual cells within the collagen gel. This result culture conditions. Specifically, both culture conditions mimicks the increase in f1-integrin staining with angiotensin 11 in resulted in a more dense staining pattern in NHFs for two-dimensional culture conditions as seen in Fig 5 PDGF stimulates collagen gel contraction via the integrins,'0 whereas transforming growth factor-a8 exhibits no such effect (authors' unpublished data). Studies examining the effects of Ang II and other growth factors may serve to elucidate the precise mechanism(s) by which Ang II and cell surface integrins are related to the control of cardiac fibroblast function.
The present study documents the expression and presence of Ang II receptors on the surface of cardiac fibroblasts by pharmacologic, biochemical, and molecular techniques. There appears to be an interaction between Ang II receptors and integrins, as revealed by the correlation of the data from immunofluorescent staining, immunolabeling, and collagen contraction assays. Specifically, the neonatal rat heart fibroblast upregulates its expression of surface p1-integrins by Ang II treatment. These results suggest a role for Ang II in mediating heart fibroblast function and may provide insight into the precise role of Ang II on heart fibroblasts in both health (physical training) and disease (hypertension).
